Amgen communicates its progress on environmental, social, and governance priorities in a variety of ways. We provide information on our website, participate in industry and investor conferences and workshops, provide information to external organizations and produce annual reports.
Our reporting reflects several international standards and guidelines, including the CDP, Sustainability Accounting Standards Board (SASB) Biotechnology & Pharmaceuticals Sustainability Accounting Standard, the United Nations Global Compact and Sustainable Development Goals (SDGs), and the recommendations of the Task Force on Climate-related Financial Disclosures (TCFD) reporting standard.
The following represents selected reporting and metrics:
Environmental, Social & Governance (ESG) Report 2022
Amgen's mission is to serve patients—and it goes beyond making vital medicines. We are working to help build a better world by focusing on the environmental, social and governance (ESG) topics that matter most to our business and to our stakeholders.
Archived ESG Reports
UNGC Communication on Progress
Amgen is a signatory of the UN Global Compact and provides an annual Communication on Progress.
Environmental Performance Data
We discuss our overall energy and carbon, water, waste and sales fleet fuel efficiency programs. We have compiled our environmental performance data and independent assurance statement in a complete summary.
We disclose climate change and water information as part of CDP's (formerly Carbon Disclosure Project) annual investor request.
Donations and Grants
We disclose donations and grants made by Amgen and the Amgen Foundation.
Securities and Exchange Commission required financial reporting
We are committed to fully complying with the disclosure requirements of the European Federation of Pharmaceutical Industries and Associations (EFPIA) codes of practice.
Reports containing our political contributions in the U.S.